Patent 10500030 was granted and assigned to TELA Bio on December, 2019 by the United States Patent and Trademark Office.
A hybrid medical device that can aid in reconstructive or augmentative surgery of the breast is disclosed. The device can utilize a suitable biological collagen tissue matrix combined with a synthetic material, for example, that can impart a high initial strength to the repair site while permitting proper healing and revitalization of the implanted device.